Nanomedicine and macroscale materials in immuno-oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanomedicine and macroscale materials in immuno-oncology

Published:2019 Issue:1 Volume:48 Page:351-381
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Sun Qingxue¹²³⁴⁵,Barz Matthias⁶⁷⁸⁹^ORCID,De Geest Bruno G.¹⁰¹¹¹²¹³^ORCID,Diken Mustafa¹⁴¹⁵⁹,Hennink Wim E.¹⁰¹⁶¹⁷¹⁸¹⁹^ORCID,Kiessling Fabian¹²³⁴⁵,Lammers Twan¹²³⁴⁵^ORCID,Shi Yang¹²³⁴⁵^ORCID

Affiliation:

1. Department of Nanomedicines and Theranostics

2. Institute for Experimental Molecular Imaging

3. Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering

4. RWTH Aachen University

5. 52074 Aachen

6. Institute of Organic Chemistry

7. Johannes Gutenberg University

8. 55099 Mainz

9. Germany

10. Department of Pharmaceutics

11. Ghent University

12. B-9000 Ghent

13. Belgium

14. TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz gGmbH

15. Mainz

16. Utrecht Institute for Pharmaceutical Sciences

17. Utrecht University

18. 3584 CG Utrecht

19. The Netherlands

Abstract

Nanomedicine and macroscale materials are increasingly impacting cancer immunotherapy.

Funder

H2020 European Research Council

Fonds Wetenschappelijk Onderzoek

Universiteit Gent

Deutsche Forschungsgemeinschaft

European Regional Development Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/CS/C8CS00473K

Reference140 articles.

1. Cancer Immunotherapy

2. Adoptive cell transfer as personalized immunotherapy for human cancer

3. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

4. Prospects for combining targeted and conventional cancer therapy with immunotherapy

5. Oncology Meets Immunology: The Cancer-Immunity Cycle

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin-Loaded Ultrasmall Gold Nanoparticles (1.5 nm) for Brain Tumor Therapy and Assessment of Their Biodistribution;ACS Applied Bio Materials;2024-09-06

2. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy;Drug Development Research;2024-08

3. Smart Cancer Nanomedicine for Synergetic Therapy;Current Medicinal Chemistry;2024-06-10

4. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy;Chemistry – A European Journal;2024-05-02

5. Bi-specific nanoparticle-based engager capable of in situ activation of anti-tumor immune responses for postoperative cancer immunotherapy;Chemical Engineering Journal;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3